Despite rich information on the KRAS and HRAS conformational changes, studies on the conformational alterations of NRAS are still lacking; hence, it is necessary to deeply investigate the influences of mutations on the conformational changes of NRAS to understand the target role of NRAS in drug development toward cancer treatment. The gene discussed is NRAS; the disease is cancer.